Insights From The HCMA Leadership Team
HCMA Board Director, Gordon Fox, MD summarizes recent Camzyos trials and finds that Camzyos eliminates (or greatly reduces) obstruction in a majority patients;with low risk of heart failure and the REMS program is effective at protecting patients from severe heart failure and its consequences.
HCM experts recommend vaccination, Gordon Fox, MD explains why increased risk of severe consequences for HCM patients, the COVID vaccine offers signifant benefits with minimum risk.